SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002;64:5260.
  • 2
    VanDyke MM, Parker JC, Smarr KL, Hewett JE, Johnson GE, Slaughter JR, et al. Anxiety in rheumatoid arthritis. Arthritis Rheum 2004;51:40812.
  • 3
    Isik A, Koca SS, Ozturk A, Mermi O. Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol 2007;26:87278.
  • 4
    Overman CL, Bossema ER, van Middendorp H, Wijngaards-de Meij L, Verstappen SM, Bulder M, et al. The prospective association between psychological distress and disease activity in rheumatoid arthritis: a multilevel regression analysis. Ann Rheum Dis 2012;71:1927.
  • 5
    Sokka T, Kautiainen H, Pincus T, Toloza S, da Rocha Castelar Pinheiro G, Lazovskis J, et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009;68:166672.
  • 6
    Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:2907.
  • 7
    Van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with “second-line” antirheumatic drugs: a randomized, controlled trial. Ann Intern Med 1996;124:699707.
  • 8
    Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, ter Borg EJ, et al, on behalf of the Utrecht Arthritis Cohort Study Group.Five-year follow-up of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year. Arthritis Rheum 2003;48:1797807.
  • 9
    Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:14439.
  • 10
    Jurgens MS, Welsing PM, Jacobs JW. Overview and analysis of treat-to-target trials in rheumatoid arthritis reporting on remission. Clin Exp Rheumatol 2012;30:S5663.
  • 11
    Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:30918.
  • 12
    Bakker MF, Jacobs JW, Welsing PM, Verstappen SM, Tekstra J, Ton E, et al. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Ann Intern Med 2012;156:32939.
  • 13
    Furst D, Breedveld F, Kalden J, Smolen JS, Burmester GR, Bijlsma JW, et al. Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Ann Rheum Dis 2005;64:iv214.
  • 14
    Smolen JS, Boers M, Abadie EC, Breedveld FC, Emery P, Bardin T, et al. Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA. Curr Med Res Opin 2011;27:31525.
  • 15
    Jung YO, Kim HA. Recent paradigm shifts in the diagnosis and treatment of rheumatoid arthritis. Korean J Intern Med 2012;27:37887.
  • 16
    Sharma P, Pathak K. Are biological targets the final goal for rheumatoid arthritis therapy?Expert Opin Biol Ther 2012;12:161122.
  • 17
    Smith RD, Polley HF. Rest therapy for rheumatoid arthritis. Mayo Clin Proc 1978;53:1415.
  • 18
    De Ridder D, Geenen R, Kuijer R, van Middendorp H. Psychological adjustment to chronic disease. Lancet 2008;372:24655.
  • 19
    De Jong Z, Munneke M, Zwinderman AH, Kroon HM, Jansen A, Ronday KH, et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum 2003;48:241524.
  • 20
    Geenen R, Mulligan K, Shipley M, Newman S. Psychosocial dimensions of the rheumatic diseases. In: Bijlsma JW, Burmeister GR, da Silva JA, Faarvang KL, Hachulla E, Mariette X, editors.EULAR compendium on rheumatic diseases.London:BMJ Publishing Group;2009. p.63550.
  • 21
    Singh JA, Christensen R, Wells GA, Suarez-Almazor ME, Buchbinder R, Lopez-Olivo MA, et al. A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. CMAJ 2009;181:78796.
  • 22
    Sokka T, Kautiainen H, Hakkinen A, Hannonen P. Radiographic progression is getting milder in patients with early rheumatoid arthritis: results of 3 cohorts over 5 years. J Rheumatol 2004;31:107382.
  • 23
    Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis 2006;65:11927.
  • 24
    Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52:100919.
  • 25
    Heiberg T, Finset A, Uhlig T, Kvien TK. Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:1915.
  • 26
    Soderlin MK, Lindroth Y, Jacobsson LT. Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmö, Sweden. Rheumatology (Oxford) 2007;46:13558.
  • 27
    Uhlig T, Heiberg T, Mowinckel P, Kvien TK. Rheumatoid arthritis is milder in the new millennium: health status in RA patients 1994-2004. Ann Rheum Dis 2008;67:17105.
  • 28
    Soderlin MK, Lindroth Y, Turesson C, Jacobsson LT. A more active treatment has profound effects on the health status of rheumatoid arthritis (RA) patients: results from a population-based RA register in Malmö, Sweden, 1997-2005. Scand J Rheumatol 2010;39:20611.
  • 29
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:31524.
  • 30
    Huiskes CJ, Kraaimaat FW, Bijlsma JW. Measuring health status in rheumatoid arthritis: development and refinement of a Dutch health status instrument. Gedrag Gezond 1990;18:7889. In Dutch.
  • 31
    Huiskes CJ, Kraaimaat FW, Bijlsma JW.IRGL: Impact of Arthritis on Health and Lifestyle self-report questionnaire.Nijmegen:University Medical Center St. Radboud Nijmegen;2004. In Dutch.
  • 32
    Zwart F, Spooren J.Development of a self-report questionnaire for depression.Utrecht:University Medical Center Utrecht;1982. In Dutch.
  • 33
    Spielberger CD, Gorsuch RL, Lushene RE.Manual of the State-Trait Anxiety Inventory.Palo Alto (CA):Consulting Psychologists Press;1970.
  • 34
    Van der Ploeg HM, Defares PB, Spielberger CD.Handleiding bij de ZelfBeoordelingsVragenlijst ZBV.Lisse:Swets & Zeitlinger;1980.
  • 35
    Fries JF, Spitz PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol 1982;9:78993.
  • 36
    Bijlsma JW, Oude Heuvel CH, Zaalberg A. Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis. J Rehabil Sci 1990;3:714.
  • 37
    Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of 3035 patients. Am J Med 2003;115:3716.
  • 38
    Krishnan E, Sokka T, Hakkinen A, Hubert H, Hannonen P. Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum 2004;50:95360.
  • 39
    Van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis: a comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol 1994;21:4259.
  • 40
    Thompson PW, Silman AJ, Kirwan JR, Currey HL. Articular indices of joint inflammation in rheumatoid arthritis: correlation with the acute-phase response. Arthritis Rheum 1987;30:61823.
  • 41
    Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008;40:87991.
  • 42
    Evers AW, Zautra A, Thieme K. Stress and resilience in rheumatic diseases: a review and glimpse into the future. Nat Rev Rheumatol 2011;7:40915.
  • 43
    Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001;933:22234.
  • 44
    Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-α in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002;26:64352.
  • 45
    Beets G, van Nimwegen N. Population issues in The Netherlands. Rev Popul Soc Policy 2000;9:87117.
  • 46
    OECD iLibrary. Education at a glance 2012: highlights.2012. URL: http://dx.doi.org/10.1787/eag_highlights-2012-en.
  • 47
    Veenhoven R. Is life getting better?Eur Psychol 2005;10:33043.
  • 48
    Twenge JM. The age of anxiety? The birth cohort change in anxiety and neuroticism, 1952-1993. J Pers Soc Psychol 2000;79:100721.
  • 49
    Welsing PM, Fransen J, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005;52:261624.
  • 50
    Boonen A, Landewe R. Health status in rheumatoid arthritis over 7 years. Ann Rheum Dis 2005;64:1735.